Considerations on the Role of Pembrolizumab Adjuvant Therapy in AJCC-8 Stage IIIA Melanoma
J Clin Oncol
.
2021 Mar 10;39(8):943-944.
doi: 10.1200/JCO.20.03213.
Epub 2021 Jan 25.
Author
Elif Hindié
1
Affiliation
1
Elif Hindi00B4 e, MD, PhD, Department of Nuclear Medicine, Bordeaux University Hospital, Bordeaux, France.
PMID:
33492983
DOI:
10.1200/JCO.20.03213
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
Humans
Melanoma* / drug therapy
Skin Neoplasms* / drug therapy
Substances
Antibodies, Monoclonal, Humanized
pembrolizumab